O(6)-Benzylguanine in Treating Patients With Malignant Glioma
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of O(6)-benzylguanine given before surgery
to patients who have malignant glioma.
Phase:
Phase 1
Details
Lead Sponsor:
North American Brain Tumor Consortium Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins